The Market Reports

Index

1 Human Vaccine Market Overview
1.1 Product Overview and Scope of Human Vaccine
1.2 Human Vaccine Segment by Type
1.2.1 Global Human Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Human Vaccine Segment by Application
1.3.1 Global Human Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Adults
1.3.3 Children
1.4 Global Human Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Vaccine Revenue 2016-2027
1.4.2 Global Human Vaccine Sales 2016-2027
1.4.3 Human Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Human Vaccine Market Competition by Manufacturers
2.1 Global Human Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Human Vaccine Market Competitive Situation and Trends
2.5.1 Human Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Vaccine Players Market Share by Revenue
2.5.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human Vaccine Retrospective Market Scenario by Region
3.1 Global Human Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Human Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Human Vaccine Market Facts & Figures by Country
3.3.1 North America Human Vaccine Sales by Country
3.3.2 North America Human Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Vaccine Market Facts & Figures by Country
3.4.1 Europe Human Vaccine Sales by Country
3.4.2 Europe Human Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Human Vaccine Sales by Region
3.5.2 Asia Pacific Human Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Vaccine Market Facts & Figures by Country
3.6.1 Latin America Human Vaccine Sales by Country
3.6.2 Latin America Human Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Vaccine Sales by Country
3.7.2 Middle East and Africa Human Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Vaccine Historic Market Analysis by Type
4.1 Global Human Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Human Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Human Vaccine Price by Type (2016-2021)

5 Global Human Vaccine Historic Market Analysis by Application
5.1 Global Human Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Human Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Human Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CNBG
6.1.1 CNBG Corporation Information
6.1.2 CNBG Description and Business Overview
6.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CNBG Human Vaccine Product Portfolio
6.1.5 CNBG Recent Developments/Updates
6.2 Changsheng Life
6.2.1 Changsheng Life Corporation Information
6.2.2 Changsheng Life Description and Business Overview
6.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Changsheng Life Human Vaccine Product Portfolio
6.2.5 Changsheng Life Recent Developments/Updates
6.3 Zhifei
6.3.1 Zhifei Corporation Information
6.3.2 Zhifei Description and Business Overview
6.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Zhifei Human Vaccine Product Portfolio
6.3.5 Zhifei Recent Developments/Updates
6.4 ChengDa Bio
6.4.1 ChengDa Bio Corporation Information
6.4.2 ChengDa Bio Description and Business Overview
6.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ChengDa Bio Human Vaccine Product Portfolio
6.4.5 ChengDa Bio Recent Developments/Updates
6.5 Kangtai
6.5.1 Kangtai Corporation Information
6.5.2 Kangtai Description and Business Overview
6.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kangtai Human Vaccine Product Portfolio
6.5.5 Kangtai Recent Developments/Updates
6.6 SINOVAC BIOTECH
6.6.1 SINOVAC BIOTECH Corporation Information
6.6.2 SINOVAC BIOTECH Description and Business Overview
6.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
6.6.5 SINOVAC BIOTECH Recent Developments/Updates
6.7 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hissen Human Vaccine Product Portfolio
6.7.5 Hissen Recent Developments/Updates
6.8 Walvax Biotechnology
6.8.1 Walvax Biotechnology Corporation Information
6.8.2 Walvax Biotechnology Description and Business Overview
6.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
6.8.5 Walvax Biotechnology Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 GSK Human Vaccine Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 SANOFI
6.10.1 SANOFI Corporation Information
6.10.2 SANOFI Description and Business Overview
6.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 SANOFI Human Vaccine Product Portfolio
6.10.5 SANOFI Recent Developments/Updates
6.11 Rong An
6.11.1 Rong An Corporation Information
6.11.2 Rong An Human Vaccine Description and Business Overview
6.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Rong An Human Vaccine Product Portfolio
6.11.5 Rong An Recent Developments/Updates
6.12 NuoCheng Bio
6.12.1 NuoCheng Bio Corporation Information
6.12.2 NuoCheng Bio Human Vaccine Description and Business Overview
6.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 NuoCheng Bio Human Vaccine Product Portfolio
6.12.5 NuoCheng Bio Recent Developments/Updates
6.13 Hualan Bio
6.13.1 Hualan Bio Corporation Information
6.13.2 Hualan Bio Human Vaccine Description and Business Overview
6.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Hualan Bio Human Vaccine Product Portfolio
6.13.5 Hualan Bio Recent Developments/Updates
6.14 Tiantan biological
6.14.1 Tiantan biological Corporation Information
6.14.2 Tiantan biological Human Vaccine Description and Business Overview
6.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Tiantan biological Human Vaccine Product Portfolio
6.14.5 Tiantan biological Recent Developments/Updates
6.15 Changchun Baike
6.15.1 Changchun Baike Corporation Information
6.15.2 Changchun Baike Human Vaccine Description and Business Overview
6.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Changchun Baike Human Vaccine Product Portfolio
6.15.5 Changchun Baike Recent Developments/Updates
6.16 Adimmune
6.16.1 Adimmune Corporation Information
6.16.2 Adimmune Human Vaccine Description and Business Overview
6.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Adimmune Human Vaccine Product Portfolio
6.16.5 Adimmune Recent Developments/Updates
6.17 Zhongyianke Biotech
6.17.1 Zhongyianke Biotech Corporation Information
6.17.2 Zhongyianke Biotech Human Vaccine Description and Business Overview
6.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
6.17.5 Zhongyianke Biotech Recent Developments/Updates
6.18 Bharat Biotech
6.18.1 Bharat Biotech Corporation Information
6.18.2 Bharat Biotech Human Vaccine Description and Business Overview
6.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Bharat Biotech Human Vaccine Product Portfolio
6.18.5 Bharat Biotech Recent Developments/Updates
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Corporation Information
6.19.2 Bavarian Nordic Human Vaccine Description and Business Overview
6.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Bavarian Nordic Human Vaccine Product Portfolio
6.19.5 Bavarian Nordic Recent Developments/Updates
6.20 Sanofi-Pasteur
6.20.1 Sanofi-Pasteur Corporation Information
6.20.2 Sanofi-Pasteur Human Vaccine Description and Business Overview
6.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
6.20.5 Sanofi-Pasteur Recent Developments/Updates
6.21 Indian Immunologicals
6.21.1 Indian Immunologicals Corporation Information
6.21.2 Indian Immunologicals Human Vaccine Description and Business Overview
6.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Indian Immunologicals Human Vaccine Product Portfolio
6.21.5 Indian Immunologicals Recent Developments/Updates
6.22 KANGH
6.22.1 KANGH Corporation Information
6.22.2 KANGH Human Vaccine Description and Business Overview
6.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.22.4 KANGH Human Vaccine Product Portfolio
6.22.5 KANGH Recent Developments/Updates
6.23 Henan Grand Biopharma
6.23.1 Henan Grand Biopharma Corporation Information
6.23.2 Henan Grand Biopharma Human Vaccine Description and Business Overview
6.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
6.23.5 Henan Grand Biopharma Recent Developments/Updates
6.24 ZhongKe Biopharm
6.24.1 ZhongKe Biopharm Corporation Information
6.24.2 ZhongKe Biopharm Human Vaccine Description and Business Overview
6.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
6.24.5 ZhongKe Biopharm Recent Developments/Updates
6.25 Zhuoyi Biological
6.25.1 Zhuoyi Biological Corporation Information
6.25.2 Zhuoyi Biological Human Vaccine Description and Business Overview
6.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
6.25.5 Zhuoyi Biological Recent Developments/Updates

7 Human Vaccine Manufacturing Cost Analysis
7.1 Human Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Vaccine
7.4 Human Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Vaccine Distributors List
8.3 Human Vaccine Customers

9 Human Vaccine Market Dynamics
9.1 Human Vaccine Industry Trends
9.2 Human Vaccine Growth Drivers
9.3 Human Vaccine Market Challenges
9.4 Human Vaccine Market Restraints

10 Global Market Forecast
10.1 Human Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Human Vaccine by Type (2022-2027)
10.2 Human Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Human Vaccine by Application (2022-2027)
10.3 Human Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Human Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Human Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Human Vaccine Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Human Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Human Vaccine Covered in This Study
Table 5. Global Human Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Human Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Human Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Human Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Human Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Human Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Human Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Vaccine Sales by Region (2016-2021) & (M Doses)
Table 16. Global Human Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Human Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 19. North America Human Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Human Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Human Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Human Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Human Vaccine Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Human Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Human Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Human Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Human Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Human Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Human Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Human Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Human Vaccine Sales (M Doses) by Type (2016-2021)
Table 39. Global Human Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Human Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Human Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Human Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global Human Vaccine Sales (M Doses) by Application (2016-2021)
Table 44. Global Human Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Human Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Human Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Human Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. CNBG Corporation Information
Table 49. CNBG Description and Business Overview
Table 50. CNBG Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. CNBG Human Vaccine Product
Table 52. CNBG Recent Developments/Updates
Table 53. Changsheng Life Corporation Information
Table 54. Changsheng Life Description and Business Overview
Table 55. Changsheng Life Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Changsheng Life Human Vaccine Product
Table 57. Changsheng Life Recent Developments/Updates
Table 58. Zhifei Corporation Information
Table 59. Zhifei Description and Business Overview
Table 60. Zhifei Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Zhifei Human Vaccine Product
Table 62. Zhifei Recent Developments/Updates
Table 63. ChengDa Bio Corporation Information
Table 64. ChengDa Bio Description and Business Overview
Table 65. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. ChengDa Bio Human Vaccine Product
Table 67. ChengDa Bio Recent Developments/Updates
Table 68. Kangtai Corporation Information
Table 69. Kangtai Description and Business Overview
Table 70. Kangtai Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Kangtai Human Vaccine Product
Table 72. Kangtai Recent Developments/Updates
Table 73. SINOVAC BIOTECH Corporation Information
Table 74. SINOVAC BIOTECH Description and Business Overview
Table 75. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. SINOVAC BIOTECH Human Vaccine Product
Table 77. SINOVAC BIOTECH Recent Developments/Updates
Table 78. Hissen Corporation Information
Table 79. Hissen Description and Business Overview
Table 80. Hissen Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Hissen Human Vaccine Product
Table 82. Hissen Recent Developments/Updates
Table 83. Walvax Biotechnology Corporation Information
Table 84. Walvax Biotechnology Description and Business Overview
Table 85. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Walvax Biotechnology Human Vaccine Product
Table 87. Walvax Biotechnology Recent Developments/Updates
Table 88. GSK Corporation Information
Table 89. GSK Description and Business Overview
Table 90. GSK Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. GSK Human Vaccine Product
Table 92. GSK Recent Developments/Updates
Table 93. SANOFI Corporation Information
Table 94. SANOFI Description and Business Overview
Table 95. SANOFI Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. SANOFI Human Vaccine Product
Table 97. SANOFI Recent Developments/Updates
Table 98. Rong An Corporation Information
Table 99. Rong An Description and Business Overview
Table 100. Rong An Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Rong An Human Vaccine Product
Table 102. Rong An Recent Developments/Updates
Table 103. NuoCheng Bio Corporation Information
Table 104. NuoCheng Bio Description and Business Overview
Table 105. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. NuoCheng Bio Human Vaccine Product
Table 107. NuoCheng Bio Recent Developments/Updates
Table 108. Hualan Bio Corporation Information
Table 109. Hualan Bio Description and Business Overview
Table 110. Hualan Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Hualan Bio Human Vaccine Product
Table 112. Hualan Bio Recent Developments/Updates
Table 113. Tiantan biological Corporation Information
Table 114. Tiantan biological Description and Business Overview
Table 115. Tiantan biological Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Tiantan biological Human Vaccine Product
Table 117. Tiantan biological Recent Developments/Updates
Table 118. Changchun Baike Corporation Information
Table 119. Changchun Baike Description and Business Overview
Table 120. Changchun Baike Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Changchun Baike Human Vaccine Product
Table 122. Changchun Baike Recent Developments/Updates
Table 123. Adimmune Corporation Information
Table 124. Adimmune Description and Business Overview
Table 125. Adimmune Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Adimmune Human Vaccine Product
Table 127. Adimmune Recent Developments/Updates
Table 128. Zhongyianke Biotech Corporation Information
Table 129. Zhongyianke Biotech Description and Business Overview
Table 130. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. Zhongyianke Biotech Human Vaccine Product
Table 132. Zhongyianke Biotech Recent Developments/Updates
Table 133. Bharat Biotech Corporation Information
Table 134. Bharat Biotech Description and Business Overview
Table 135. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Bharat Biotech Human Vaccine Product
Table 137. Bharat Biotech Recent Developments/Updates
Table 138. Bavarian Nordic Corporation Information
Table 139. Bavarian Nordic Description and Business Overview
Table 140. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. Bavarian Nordic Human Vaccine Product
Table 142. Bavarian Nordic Recent Developments/Updates
Table 143. Sanofi-Pasteur Corporation Information
Table 144. Sanofi-Pasteur Description and Business Overview
Table 145. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. Sanofi-Pasteur Human Vaccine Product
Table 147. Sanofi-Pasteur Recent Developments/Updates
Table 148. Indian Immunologicals Corporation Information
Table 149. Indian Immunologicals Description and Business Overview
Table 150. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 151. Indian Immunologicals Human Vaccine Product
Table 152. Indian Immunologicals Recent Developments/Updates
Table 153. KANGH Corporation Information
Table 154. KANGH Description and Business Overview
Table 155. KANGH Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 156. KANGH Human Vaccine Product
Table 157. KANGH Recent Developments/Updates
Table 158. Henan Grand Biopharma Corporation Information
Table 159. Henan Grand Biopharma Description and Business Overview
Table 160. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 161. Henan Grand Biopharma Human Vaccine Product
Table 162. Henan Grand Biopharma Recent Developments/Updates
Table 163. ZhongKe Biopharm Corporation Information
Table 164. ZhongKe Biopharm Description and Business Overview
Table 165. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 166. ZhongKe Biopharm Human Vaccine Product
Table 167. ZhongKe Biopharm Recent Developments/Updates
Table 168. Zhuoyi Biological Corporation Information
Table 169. Zhuoyi Biological Description and Business Overview
Table 170. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 171. Zhuoyi Biological Human Vaccine Product
Table 172. Zhuoyi Biological Recent Developments/Updates
Table 173. Production Base and Market Concentration Rate of Raw Material
Table 174. Key Suppliers of Raw Materials
Table 175. Human Vaccine Distributors List
Table 176. Human Vaccine Customers List
Table 177. Human Vaccine Market Trends
Table 178. Human Vaccine Growth Drivers
Table 179. Human Vaccine Market Challenges
Table 180. Human Vaccine Market Restraints
Table 181. Global Human Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 182. Global Human Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 183. Global Human Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 184. Global Human Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 185. Global Human Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 186. Global Human Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 187. Global Human Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 188. Global Human Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 189. Global Human Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 190. Global Human Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 191. Global Human Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 192. Global Human Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Vaccine
Figure 2. Global Human Vaccine Market Share by Type in 2020 & 2027
Figure 3. Varicella Product Picture
Figure 4. Influenza Product Picture
Figure 5. Polio Product Picture
Figure 6. Hepatitis A Product Picture
Figure 7. Rabies Product Picture
Figure 8. BCG Product Picture
Figure 9. Hepatitis B Product Picture
Figure 10. Pertussis, Diphtheria, Tetanus Product Picture
Figure 11. Pneumococcal Product Picture
Figure 12. Rota vaccine Product Picture
Figure 13. Global Human Vaccine Market Share by Application in 2020 & 2027
Figure 14. Adults
Figure 15. Children
Figure 16. Global Human Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Human Vaccine Market Size 2016-2027 (US$ Million)
Figure 18. Global Human Vaccine Sales 2016-2027 (M Doses)
Figure 19. Global Human Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Human Vaccine Sales Share by Manufacturers in 2020
Figure 21. Global Human Vaccine Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Human Vaccine Players: Market Share by Revenue in 2020
Figure 23. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Human Vaccine Sales Market Share by Region (2016-2021)
Figure 25. Global Human Vaccine Sales Market Share by Region in 2020
Figure 26. Global Human Vaccine Revenue Market Share by Region (2016-2021)
Figure 27. Global Human Vaccine Revenue Market Share by Region in 2020
Figure 28. U.S. Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E Human Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of Human Vaccine by Type (2016-2021)
Figure 53. Sales Market Share of Human Vaccine by Application (2016-2021)
Figure 54. Sales Market Share of Human Vaccine by Application in 2020
Figure 55. Revenue Share of Human Vaccine by Application (2016-2021)
Figure 56. Revenue Share of Human Vaccine by Application in 2020
Figure 57. Manufacturing Cost Structure of Human Vaccine
Figure 58. Manufacturing Process Analysis of Human Vaccine
Figure 59. Human Vaccine Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed